Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.

Eric M. Reiman, Guy M. McKhann, Marilyn S. Albert, Reisa A. Sperling, Ronald Carl Petersen, Deborah Blacker

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Almost 30 years ago, the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (more commonly known as the Alzheimer's Association) developed the original clinical diagnostic criteria for Alzheimer's disease (AD). Recently, the National Institute on Aging and the Alzheimer's Association released updated research and diagnostic criteria for AD. The new criteria establish that AD exists on a continuum and is comprised of not only dementia but also a preclinical phase and a phase of mild cognitive impairment due to AD. The new criteria also describe advancements in biomarker evidence, which is still being researched and is not yet ready for clinical settings. Additionally, the American Psychiatric Association is currently revising the Diagnostic and Statistical Manual of Mental Disorders, which will include updated diagnostic criteria for AD and other neurocognitive disorders.

Original languageEnglish (US)
JournalThe Journal of clinical psychiatry
Volume72
Issue number12
StatePublished - Dec 2011

Fingerprint

Alzheimer Disease
Research
National Institute on Aging (U.S.)
National Institute of Neurological Disorders and Stroke
Communication Disorders
Diagnostic and Statistical Manual of Mental Disorders
Dementia
Biomarkers

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Reiman, E. M., McKhann, G. M., Albert, M. S., Sperling, R. A., Petersen, R. C., & Blacker, D. (2011). Clinical impact of updated diagnostic and research criteria for Alzheimer's disease. The Journal of clinical psychiatry, 72(12).

Clinical impact of updated diagnostic and research criteria for Alzheimer's disease. / Reiman, Eric M.; McKhann, Guy M.; Albert, Marilyn S.; Sperling, Reisa A.; Petersen, Ronald Carl; Blacker, Deborah.

In: The Journal of clinical psychiatry, Vol. 72, No. 12, 12.2011.

Research output: Contribution to journalArticle

Reiman, EM, McKhann, GM, Albert, MS, Sperling, RA, Petersen, RC & Blacker, D 2011, 'Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.', The Journal of clinical psychiatry, vol. 72, no. 12.
Reiman, Eric M. ; McKhann, Guy M. ; Albert, Marilyn S. ; Sperling, Reisa A. ; Petersen, Ronald Carl ; Blacker, Deborah. / Clinical impact of updated diagnostic and research criteria for Alzheimer's disease. In: The Journal of clinical psychiatry. 2011 ; Vol. 72, No. 12.
@article{fc2db60f0f7844cc8d6dfb7644b8ccc9,
title = "Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.",
abstract = "Almost 30 years ago, the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (more commonly known as the Alzheimer's Association) developed the original clinical diagnostic criteria for Alzheimer's disease (AD). Recently, the National Institute on Aging and the Alzheimer's Association released updated research and diagnostic criteria for AD. The new criteria establish that AD exists on a continuum and is comprised of not only dementia but also a preclinical phase and a phase of mild cognitive impairment due to AD. The new criteria also describe advancements in biomarker evidence, which is still being researched and is not yet ready for clinical settings. Additionally, the American Psychiatric Association is currently revising the Diagnostic and Statistical Manual of Mental Disorders, which will include updated diagnostic criteria for AD and other neurocognitive disorders.",
author = "Reiman, {Eric M.} and McKhann, {Guy M.} and Albert, {Marilyn S.} and Sperling, {Reisa A.} and Petersen, {Ronald Carl} and Deborah Blacker",
year = "2011",
month = "12",
language = "English (US)",
volume = "72",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "12",

}

TY - JOUR

T1 - Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.

AU - Reiman, Eric M.

AU - McKhann, Guy M.

AU - Albert, Marilyn S.

AU - Sperling, Reisa A.

AU - Petersen, Ronald Carl

AU - Blacker, Deborah

PY - 2011/12

Y1 - 2011/12

N2 - Almost 30 years ago, the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (more commonly known as the Alzheimer's Association) developed the original clinical diagnostic criteria for Alzheimer's disease (AD). Recently, the National Institute on Aging and the Alzheimer's Association released updated research and diagnostic criteria for AD. The new criteria establish that AD exists on a continuum and is comprised of not only dementia but also a preclinical phase and a phase of mild cognitive impairment due to AD. The new criteria also describe advancements in biomarker evidence, which is still being researched and is not yet ready for clinical settings. Additionally, the American Psychiatric Association is currently revising the Diagnostic and Statistical Manual of Mental Disorders, which will include updated diagnostic criteria for AD and other neurocognitive disorders.

AB - Almost 30 years ago, the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (more commonly known as the Alzheimer's Association) developed the original clinical diagnostic criteria for Alzheimer's disease (AD). Recently, the National Institute on Aging and the Alzheimer's Association released updated research and diagnostic criteria for AD. The new criteria establish that AD exists on a continuum and is comprised of not only dementia but also a preclinical phase and a phase of mild cognitive impairment due to AD. The new criteria also describe advancements in biomarker evidence, which is still being researched and is not yet ready for clinical settings. Additionally, the American Psychiatric Association is currently revising the Diagnostic and Statistical Manual of Mental Disorders, which will include updated diagnostic criteria for AD and other neurocognitive disorders.

UR - http://www.scopus.com/inward/record.url?scp=84872466223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872466223&partnerID=8YFLogxK

M3 - Article

C2 - 22244033

AN - SCOPUS:84872466223

VL - 72

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 12

ER -